TY - JOUR
T1 - Atherosclerosis
T2 - The low-density lipoprotein receptor hypothesis
AU - Goldstein, Joseph L.
AU - Brown, Michael S.
N1 - Funding Information:
From the Division of Medical Genetics, Departmenr of Internal Medicine, University of Texas Healrh Science Center, Dallas. Texas. Receivedfor publication March 18. 1977. Supported b_v grants from the National Institutes of Health, the National Foundation-March Dimes. and the .4 merican Heart Association. Reprint requests should be addressed to Dr. Joseph L. Goldstein, Department of Internal Medicine, University of Texas Health Science Center, 5323 Harry Hines Blvd., Dallas, Texas 75235. ‘CJ1 977 bv Grune & Stratton, Inc. ISSN 0026-0495.
PY - 1977/11
Y1 - 1977/11
N2 - Recent biochemical, genetic, and ultrastructural studies have disclosed that non-hepatic human cells, such as fibroblasts, lymphocytes, and aortic smooth muscle cells, utilize a specific metabolic pathway, the low-density lipoprotein (LDL) pathway, to supply themselves with cholesterol. The critical component of this pathway is a specific high-affinity receptor on the cell surface that binds LDL, the major cholesterol-carrying lipoprotein of human plasma. Cellular uptake of the receptor-bound LDL is followed by intralysosomal degradation of the lipoprotein with release of its cholesterol for use in cellular membrane synthesis. When the LDL receptor is genetically absent, as in the homozygous form of familial hypercholesterolemia, the degradation of LDL is impaired, the lipoprotein accumulates to very high levels in the plasma, and a severe form of atherosclerosis ensues. In this paper we present the hypothesis that the normal function of the high-affinity cell-surface LDL receptor is to allow non-hepatic cells to supply themselves with cholesterol at a time when the LDL concentration in plasma is maintained at low levels. We then discuss a mechanism by which this hypothesis might explain the widespread occurrence of atherosclerosis in humans with "normal" plasma LDL-cholesterol levels. The data on the LDL pathway lend biochemical support to the conclusion previously derived from epidemiologic studies-namely, that the "normal" plasma level of LDL-cholesterol in Western man is unphysiologically high.
AB - Recent biochemical, genetic, and ultrastructural studies have disclosed that non-hepatic human cells, such as fibroblasts, lymphocytes, and aortic smooth muscle cells, utilize a specific metabolic pathway, the low-density lipoprotein (LDL) pathway, to supply themselves with cholesterol. The critical component of this pathway is a specific high-affinity receptor on the cell surface that binds LDL, the major cholesterol-carrying lipoprotein of human plasma. Cellular uptake of the receptor-bound LDL is followed by intralysosomal degradation of the lipoprotein with release of its cholesterol for use in cellular membrane synthesis. When the LDL receptor is genetically absent, as in the homozygous form of familial hypercholesterolemia, the degradation of LDL is impaired, the lipoprotein accumulates to very high levels in the plasma, and a severe form of atherosclerosis ensues. In this paper we present the hypothesis that the normal function of the high-affinity cell-surface LDL receptor is to allow non-hepatic cells to supply themselves with cholesterol at a time when the LDL concentration in plasma is maintained at low levels. We then discuss a mechanism by which this hypothesis might explain the widespread occurrence of atherosclerosis in humans with "normal" plasma LDL-cholesterol levels. The data on the LDL pathway lend biochemical support to the conclusion previously derived from epidemiologic studies-namely, that the "normal" plasma level of LDL-cholesterol in Western man is unphysiologically high.
UR - http://www.scopus.com/inward/record.url?scp=0017719024&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0017719024&partnerID=8YFLogxK
U2 - 10.1016/0026-0495(77)90119-6
DO - 10.1016/0026-0495(77)90119-6
M3 - Article
C2 - 198627
AN - SCOPUS:0017719024
SN - 0026-0495
VL - 26
SP - 1257
EP - 1275
JO - Metabolism
JF - Metabolism
IS - 11
ER -